These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 4892079)

  • 1. [A study of the streptomycin-dependent mutants of shigella].
    Sergeev VV; Taratorina OM; Elkina SI
    Zh Mikrobiol Epidemiol Immunobiol; 1967 Sep; 44(9):28-32. PubMed ID: 4892079
    [No Abstract]   [Full Text] [Related]  

  • 2. Immunogenic value of live, inactivated and cell-free dysentery vaccines.
    Meitert T; Sulea IT; Gogulescu L; Baron E; Tempea C; Istrati G
    Acta Microbiol Acad Sci Hung; 1974; 21(1-2):103-7. PubMed ID: 4613127
    [No Abstract]   [Full Text] [Related]  

  • 3. [Safety, reactivity and effectiveness testing of live shigella flexneri vaccines in laboratory animals and children (author's transl)].
    Sergeev VV; Elkina SI; Solodnikov YP; Shuster BY; Sergeeva GS; Bulk VF; Bobkin SV
    Acta Microbiol Acad Sci Hung; 1974; 21(1-2):121-8. PubMed ID: 4216247
    [No Abstract]   [Full Text] [Related]  

  • 4. Studies on vaccination against bacillary dysentery. 6. Protection of children by oral immunization with streptomycin-dependent Shigella strains.
    Mel D; Gangarosa EJ; Radovanovic ML; Arsic BL; Litvinjenko S
    Bull World Health Organ; 1971; 45(4):457-64. PubMed ID: 4948417
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Live shigella flexneri 2a and shigella sonnei vaccines (author's transl)].
    Belaia IuA; Gekker VD; Kuz'min SN; Sergeeva NS
    Acta Microbiol Acad Sci Hung; 1974; 21(1-2):63-9. PubMed ID: 4216253
    [No Abstract]   [Full Text] [Related]  

  • 6. Efficacy of a polyvalent protein-polysaccharide dysentery oral vaccine.
    Zhang HM; Li YP; Song LH; Yu XL; Liu NH; Kong XE; Li L; Zhai YL
    Chin Med J (Engl); 1987 May; 100(5):425-8. PubMed ID: 3115716
    [No Abstract]   [Full Text] [Related]  

  • 7. Clinical trials of Shigella vaccines in Israel.
    Cohen D; Ashkenazi S; Green M; Gdalevich M; Yavzori M; Orr N; Robin G; Slepon R; Lerman Y; Block C; Ashkenazi I; Taylor D; Hale L; Sadoff J; Schneerson R; Robbins J; Wiener M; Shemer J
    Adv Exp Med Biol; 1996; 397():159-67. PubMed ID: 8718595
    [No Abstract]   [Full Text] [Related]  

  • 8. Shigella Sonnei vaccine.
    Drugs R D; 1999 Sep; 2(3):222-3. PubMed ID: 10641235
    [No Abstract]   [Full Text] [Related]  

  • 9. [The pathogenic properties of streptomycin-dependent mutants of Sh. flexneri and its revertants].
    Mikhaĭlov IF; Sergeev VV; Elkina SI
    Zh Mikrobiol Epidemiol Immunobiol; 1968 Nov; 45(11):10-4. PubMed ID: 5735219
    [No Abstract]   [Full Text] [Related]  

  • 10. [On the problem of specific prevention of dysentery. I. Selection of avirulent immunogenic strains of Flexner and Sonne dysentery bacteria].
    Belaia IuA
    Zh Mikrobiol Epidemiol Immunobiol; 1968 Apr; 45(4):14-9. PubMed ID: 4898256
    [No Abstract]   [Full Text] [Related]  

  • 11. [Use of the keratoconjunctival model in guinea pigs for quantitative assessment of the immunogenicity of dysentery antigens].
    Korneeva SA; Solov'eva OG
    Zh Mikrobiol Epidemiol Immunobiol; 1977 Oct; (10):139-40. PubMed ID: 335731
    [No Abstract]   [Full Text] [Related]  

  • 12. Immunity of the guinea pig's eye after vaccination with Shigella sonnei phase I antigen.
    Kerekes L
    Acta Microbiol Acad Sci Hung; 1976; 23(4):353-8. PubMed ID: 799899
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A morphologic study of the harmlessness of live dysentery vaccines from streptomycin dependent mutants of Sh. flexneri].
    Levenbuk IS; Sergeev VV; Elkina SI; Kavtaradze KN; Dzhikidze EK
    Zh Mikrobiol Epidemiol Immunobiol; 1972 Feb; 49(2):18-22. PubMed ID: 4623775
    [No Abstract]   [Full Text] [Related]  

  • 14. Live oral Shigella vaccine: vaccination schedule and the effect of booster dose.
    Mel DM; Arsic BL; Radovanovic ML; Litvinjenko SA
    Acta Microbiol Acad Sci Hung; 1974; 21(1-2):109-14. PubMed ID: 4613128
    [No Abstract]   [Full Text] [Related]  

  • 15. Development and administration of live Shigella vaccines.
    Pencu E
    Arch Roum Pathol Exp Microbiol; 1984; 43(3-4):231-50. PubMed ID: 6443689
    [No Abstract]   [Full Text] [Related]  

  • 16. [Studies of crossed immunity between different serotypes of dysentery bacilli and the keratoconjunctivitis-positive, lactoso-negative strain 47552 deprived of Shigella agglutinogen].
    Ciufeco C
    Arch Roum Pathol Exp Microbiol; 1969; 28(2):389-94. PubMed ID: 4925072
    [No Abstract]   [Full Text] [Related]  

  • 17. Effective stimulation of the mucosal immune response by parenteral vaccination with weak antigen associated with a nucleoprotein vehicle.
    Levenson VJ; Egorova TP
    Ann N Y Acad Sci; 1994 Aug; 730():353-5. PubMed ID: 8080208
    [No Abstract]   [Full Text] [Related]  

  • 18. [Specific disappearance of macrophages from the peritoneal exudate of guinea pigs following administration of Sh. sonnei endotoxin].
    Solov'eva OG; Korneeva SA
    Zh Mikrobiol Epidemiol Immunobiol; 1980; (2):62-6. PubMed ID: 6994415
    [No Abstract]   [Full Text] [Related]  

  • 19. Safety and immunogenicity of Shigella sonnei and Shigella flexneri 2a O-specific polysaccharide conjugates in children.
    Ashkenazi S; Passwell JH; Harlev E; Miron D; Dagan R; Farzan N; Ramon R; Majadly F; Bryla DA; Karpas AB; Robbins JB; Schneerson R
    J Infect Dis; 1999 Jun; 179(6):1565-8. PubMed ID: 10228084
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An outbreak of Sonne shigellosis in a population receiving oral attenuated shigella vaccines.
    Levine MM; Rice PA; Gangarosa EJ; Morris GK; Snyder MJ; Formal SB; Wells JG; Gemski P; Hammond J
    Am J Epidemiol; 1974 Jan; 99(1):30-6. PubMed ID: 4590191
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.